Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

BlackRock Health Sciences Trust logo
$39.04 +0.37 (+0.94%)
As of 11:19 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About BlackRock Health Sciences Trust Stock (NYSE:BME)

Key Stats

Today's Range
$38.80
$39.10
50-Day Range
$36.92
$41.29
52-Week Range
$36.87
$42.75
Volume
11,267 shs
Average Volume
75,767 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

BME Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.
BME And FLC: There Are Still Pockets Of Opportunities
BME: 8.4% Yield From An Undervalued Sector
See More Headlines

BME Stock Analysis - Frequently Asked Questions

BlackRock Health Sciences Trust's stock was trading at $37.93 at the beginning of 2025. Since then, BME stock has increased by 2.8% and is now trading at $39.0090.
View the best growth stocks for 2025 here
.

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include Enterprise Products Partners (EPD), Verizon Communications (VZ), Mplx (MPLX), BlackRock Science and Technology Trust (BST), Johnson & Johnson (JNJ), Pfizer (PFE) and Main Street Capital (MAIN).

Company Calendar

Ex-Dividend for 12/23 Dividend
12/16/2024
Dividend Payable
12/23/2024
Today
1/15/2025
Ex-Dividend for 1/31 Dividend
1/15/2025
Dividend Payable
1/31/2025

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
Financial Services
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$55.05 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:BME) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners